 Home > Medical News > Latest Medical News > Luye Pharma's Alzheimer's innovative drug Liss' Mingdo Day transdermal patch is approved for marketing in the UK

Luye Pharma's Alzheimer's innovative drug Liss' Mingdo Day transdermal patch is approved for marketing in the UK

 Last Update: 2021-09-30
 Source: Internet
 Author: User

Tags

u2os cell line

uk business search

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Guildford, United Kingdom, September 23, 2021/PRNewswire/ - Luye Pharmaceutical Group announced that its self-developed innovative preparation, Liss’ Mindo Day Transdermal Patch, has been approved by the British Drug and Health Products Regulatory Agency ( Medicines and Healthcare products Regulatory Agency) for the treatment of mild and moderate dementia related to Alzheimer’s disease

The branch of Luye Pharmaceutical Group in the UK is the UK marketing license holder of Liss’ Mingdo Day transdermal patch, and will fully lead the local commercial operation of the product, covering market supervision, product promotion, distribution, and supply chain Management and other links

Alzheimer's disease is an irreversible neurodegenerative disease that causes a progressive decline in patients' memory and other cognitive aspects

Liss’s Mingdo Day transdermal patch is developed by Luye Pharma’s proprietary transdermal drug delivery technology platform and has a number of international patents

"The number of patients with Alzheimer's disease is increasing, but the existing treatment options are very limited

In order to bring this new treatment option to more patients as soon as possible, Luye Pharma is accelerating the development and commercialization of Liss’ Mindoday transdermal patch in the global market

About Liss' Mindo Day Transdermal Patch

Liszmin's transdermal patch is an innovative patch formulation of Liszmin's twice a week for the treatment of mild to moderate dementia related to Alzheimer's disease

Listigmine is a cholinesterase inhibitor drug

About Luye Pharmaceutical Group

Luye Pharmaceutical Group (Luye Pharmaceutical) is an international pharmaceutical company dedicated to the development, production and sales of innovative drugs

Luye Pharma has a deep layout of the global supply chain system.

[i] "2019 Alzheimer's Disease Facts and Figures Report".

https://

[ii] "World Alzheimer's Disease Report 2019".

https:// Luye Pharma

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.